Keppra
Product Images NDC 21695-070

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Keppra (NDC 21695-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (D1329893 A8bc 4f31 A31b 76690d111035 01)

Chemical structure of the active ingredient in Keppra, showing a pyrrolidone ring with attached ethyl and amide groups. The diagram depicts molecular connectivity and functional groups typical of levetiracetam, the active compound in Keppra.*

FDA Label Image

Figure (D1329893 A8bc 4f31 A31b 76690d111035 02)

A vertical bar chart comparing the percentage of patients across three groups: Placebo (N=95) at 7.4%, Keppra 1000 mg/day (N=97) at 37.1%, and Keppra 3000 mg/day (N=101) at 39.6%. The y-axis shows percentages from 0% to 45%, and each bar has an asterisk above the percentage values.*

FDA Label Image

Figure (D1329893 A8bc 4f31 A31b 76690d111035 03)

A bar chart showing the percentage of patients in three groups: Placebo (111 patients) with 6.3%, Keppra 1000 mg/day (106 patients) with 20.8%, and Keppra 2000 mg/day (105 patients) with 35.2%. The y-axis represents the percentage of patients ranging from 0% to 45% and each bar is labeled with the exact percentage above it.*

FDA Label Image

Figure (D1329893 A8bc 4f31 A31b 76690d111035 04)

A bar graph comparing the percentage of patients for Placebo and Keppra 3000 mg/day groups. The y-axis represents the percentage of patients, reaching up to 45%. Placebo group has about 14.4% patients, while Keppra 3000 mg/day group shows approximately 39.4% patients. Sample sizes are 104 for Placebo and 180 for Keppra.*

FDA Label Image

Figure (D1329893 A8bc 4f31 A31b 76690d111035 05)

A bar chart comparing the percentage of patients for two groups: Placebo with 19.6% and Keppra with 44.6%. The y-axis is labeled '% of Patients', and the x-axis labels indicate the groups and their sample sizes (Placebo N=97, Keppra N=101). A star symbol is present above the Keppra bar.*

FDA Label Image

Figure (D1329893 A8bc 4f31 A31b 76690d111035 06)

A bar chart comparing the percentage of patients between a placebo group (N=84) and a Keppra group (N=79). The Y-axis represents the percentage of patients from 0% to 100%. The Keppra group shows 72.2% while the placebo group shows 45.2%.*

FDA Label Image

Keppra 500mg (D1329893 A8bc 4f31 A31b 76690d111035 07)

Keppra 500 mg tablets label, distributed by Rebel Distributors Corp. The label indicates each tablet contains levetiracetam 500 mg. The package size is 15 tablets. Additional details include the NDC 21695-070-15 and manufacturer information for UCB S.A., Belgium. The label features physician partner branding and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.